Novavax: Licensing

(asked on 10th January 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what progress is being made on the approval of Novavax for use in the UK; and if he will make a statement.


Answered by
Maria Caulfield Portrait
Maria Caulfield
Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
This question was answered on 17th January 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) is unable to comment on products not approved for use in the United Kingdom due to commercial and market sensitivities. We are therefore unable to provide a timetable for the approval of the Novavax vaccine. Any route to approval of new vaccine treatments will be subject to the developer seeking regulatory approval from the MHRA. As with all other COVID-19 vaccines, the MHRA will ensure a thorough and expedited assessment of its safety and efficacy before any authorisation.

Reticulating Splines